Tuesday, November 16, 2010
Dendreon is developing an HER-2 Theraputic vaccine called Neuvenge. This is an antigen expressed by breast, bladder, gastric, colorectal and ovarian cancer.
This is another new paradigm drug that could save more millions of lives.
If this is given before any other procedures it may be the only needed therapy.
This would really shakeup the oncology industry. $60 billion/yr reduced. WOW!
Labels:
Bladder cancer,
Breast cancer,
Colorectal cancer,
HER-2,
Neuvenge,
Ovarian cancer
Wednesday, March 31, 2010
Monday, January 4, 2010
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Denosumab, Osteoporosis, and Prevention of Fractures
This clinical trial appears to have been successful. One of the side effects of androgen deprevation therapy is bone loss. Woman who have osteoporosis have been known to shatter their spine by turning over in bed.
This is a general aging issue. I personally
ClinicalTrials.gov number, NCT00089674
This clinical trial appears to have been successful. One of the side effects of androgen deprevation therapy is bone loss. Woman who have osteoporosis have been known to shatter their spine by turning over in bed.
This is a general aging issue. I personally
ClinicalTrials.gov number, NCT00089674
Sunday, January 3, 2010
Great Truths Pass Thru 3 Stages--This truth is very Important in cTrials
"“All great truth passes through three stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident.” - Arthur Schopenhauer"
Friday, January 1, 2010
Subscribe to:
Posts (Atom)